Walleye Trading’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,540
Closed -$718K 4835
2023
Q1
$718K Buy
+1,540
New +$815K ﹤0.01% 2503
2022
Q2
Sell
-24
Closed -$7K 5297
2022
Q1
$7K Buy
24
+16
+200% +$5.58K ﹤0.01% 5037
2021
Q4
$3K Sell
8
-3,544
-100% -$1.1M ﹤0.01% 5235
2021
Q3
$908K Buy
3,552
+3,548
+88,700% +$1.26M ﹤0.01% 2308
2021
Q2
$3K Buy
+4
New +$2.3K ﹤0.01% 5039
2021
Q1
Sell
-300
Closed -$278K 4946
2020
Q4
$278K Sell
300
-1,856
-86% -$1.95M ﹤0.01% 3212
2020
Q3
$2.22M Sell
2,156
-184
-8% -$198K 0.01% 1054
2020
Q2
$2.37M Hold
2,340
0.02% 971
2020
Q1
$2.03M Buy
2,340
+1,752
+298% +$1.74M 0.02% 818
2019
Q4
$630K Buy
588
+304
+107% +$310K ﹤0.01% 2210
2019
Q3
$263K Buy
284
+36
+15% +$39.5K ﹤0.01% 2710
2019
Q2
$280K Buy
+248
New +$271K ﹤0.01% 2665
2018
Q4
Sell
-172
Closed -$261K 4846
2018
Q3
$261K Sell
172
-96
-36% -$148K ﹤0.01% 3536
2018
Q2
$419K Sell
268
-272
-50% -$355K ﹤0.01% 2997
2018
Q1
$624K Buy
+540
New +$711K ﹤0.01% 2422

Other funds holding KYNB

Walleye Trading's KYNB Position: Q2 2023 in Review

Walleye Trading sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 246 shares — an estimated $102K sold.

Walleye Trading first reported a position in KYNB in Q2 2016 and held it in 13 quarters. The position peaked at $1.47M in Q2 2021. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Walleye Trading reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 246 Kyntra Bio shares in Q2 2023, an estimated $102K.
  • Walleye Trading first reported a position in Kyntra Bio in Q2 2016 and held it in 13 quarters.
  • Walleye Trading's Kyntra Bio position peaked at $1.47M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.